Department of Pharmacology, Pharmacy and Pharmaceutical Technology
Department
Instituto de Oftalmología Aplicada de Valladolid
Valladolid, EspañaPublications in collaboration with researchers from Instituto de Oftalmología Aplicada de Valladolid (10)
2018
-
Sorbitan ester nanoparticles (SENS) as a novel topical ocular drug delivery system: Design, optimization, and in vitro/ex vivo evaluation
International Journal of Pharmaceutics, Vol. 546, Núm. 1-2, pp. 20-30
-
Xanthan gum-functionalised span nanoparticles for gene targeting to endothelial cells
Colloids and Surfaces B: Biointerfaces, Vol. 170, pp. 411-420
2017
-
Designing lipid nanoparticles for topical ocular drug delivery
International Journal of Pharmaceutics, Vol. 532, Núm. 1, pp. 204-217
2014
-
Nanoparticles based on naturally-occurring biopolymers as versatile delivery platforms for delicate bioactive molecules: An application for ocular gene silencing
International Journal of Pharmaceutics, Vol. 477, Núm. 1, pp. 12-20
2013
-
A nanomedicine to treat ocular surface inflammation: Performance on an experimental dry eye murine model
Gene Therapy, Vol. 20, Núm. 5, pp. 467-477
2011
-
Expression of MUC5AC in ocular surface epithelial cells using cationized gelatin nanoparticles
Molecular Pharmaceutics, Vol. 8, Núm. 5, pp. 1783-1788
-
Intracellular trafficking of hyaluronic acid-chitosan oligomerbased nanoparticles in cultured human ocular surface cells
Molecular Vision, Vol. 17, pp. 279-290
2010
-
Ocular tolerance to a topical formulation of hyaluronic acid and chitosan-based nanoparticles
Cornea, Vol. 29, Núm. 5, pp. 550-558
2004
-
Chitosan nanoparticles as new ocular drug delivery systems: In vitro stability, in vivo fate, and cellular toxicity
Pharmaceutical Research, Vol. 21, Núm. 5, pp. 803-810
2002
-
Efficacy and safety of microspheres of cyclosporin A, a new systemic formulation, to prevent corneal graft rejection in rats
Current Eye Research, Vol. 24, Núm. 1, pp. 39-45